Document Type
Article
Publication Date
10-5-2017
Publication Title
FUTURE SCIENCE OA
Volume
3
Issue
4
First page number:
1
Last page number:
8
Abstract
Carbapenem-resistant Enterobacteriaceae (CRE) are a family of bacteria that can result in deadly infections because they are resistant to most antibiotics. We obtained 54 Klebsiella pneumonia carbapenemase isolates, a type of CRE, and determined which antibiotics were effective against them. Results showed that five isolates that were considered susceptible to an antibiotic under the previous criteria were now considered nonsusceptible with the current standards. This study shows that the current criteria may not offer additional benefits in the fight against CRE infections. Studies such as this one and prudent use of antibiotics should limit the spread of antibiotic resistance.
Keywords
Antibiotics, Antimicrobial stewardship, Carbapenem, Carbapenem resistance, Clinical and Laboratory Standards Institute, Klebsiella pneumoniae
File Format
File Size
574 KB
Language
English
Rights
IN COPYRIGHT. For more information about this rights statement, please visit http://rightsstatements.org/vocab/InC/1.0/
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Repository Citation
Enyinnaya, F.,
Cruz Perez, P.,
Buttner, M. P.,
Cross, C.,
Woodard, D. R.
(2017).
Comparison of Clinical & Laboratory Standards Institute standards in antimicrobial susceptibility among the carbapenemase producing Enterobacteriaceae.
FUTURE SCIENCE OA, 3(4),
1-8.
http://dx.doi.org/10.4155/fsoa-2017-0095